Compare GKOS & SLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | SLAB |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.2B |
| IPO Year | 2015 | 2000 |
| Metric | GKOS | SLAB |
|---|---|---|
| Price | $146.06 | $218.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 11 |
| Target Price | $126.92 | ★ $163.13 |
| AVG Volume (30 Days) | ★ 928.7K | 393.0K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.61 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $507,442,000.00 | $491,625,000.00 |
| Revenue This Year | $23.32 | $20.49 |
| Revenue Next Year | $27.43 | $16.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $115.51 |
| 52 Week High | $148.62 | $220.90 |
| Indicator | GKOS | SLAB |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 50.10 |
| Support Level | $96.44 | $217.03 |
| Resistance Level | N/A | $219.75 |
| Average True Range (ATR) | 5.65 | 1.83 |
| MACD | 1.60 | -0.23 |
| Stochastic Oscillator | 98.92 | 39.00 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.